Neurogene Inc. (NGNE)

USD 16.97

(10.19%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - 25 Million
Cost of Revenue 3.26 Million 3.19 Million 2.27 Million 1.82 Million 340 Thousand -
Gross Profit -3.26 Million -3.19 Million -2.27 Million -1.82 Million -340 Thousand 25 Million
Operating Expenses 55.58 Million 56.51 Million 50.53 Million 39.73 Million 24.1 Million 48.52 Million
Selling, General and Administrative Expenses 11.18 Million 9.01 Million 8.27 Million 15.38 Million 17.78 Million 15.73 Million
Research and Development Expenses 44.39 Million 47.5 Million 42.26 Million 24.34 Million 6.31 Million 32.78 Million
Other Expenses - -7000.00 - - - -
Cost and Expenses 55.58 Million 56.51 Million 50.53 Million 41.55 Million 24.44 Million 48.52 Million
Operating Income -55.58 Million -56.51 Million -50.53 Million -41.55 Million -24.44 Million -23.52 Million
Interest Expense 12 Thousand 2000.00 - - 1000.00 4000.00
Income Tax Expense - -5000.00 17 Thousand -1.00 168.14 Thousand -
Earnings before Tax -36.31 Million -55.18 Million -50.51 Million -33.27 Million -69.44 Million -31.58 Million
Net Income -36.31 Million -55.18 Million -50.51 Million -33.27 Million -69.44 Million -31.58 Million
Earnings Per Share Basic -2.83 -4.30 -0.92 -0.64 -2.57 -1.34
Earnings Per Share Diluted -2.83 -4.30 -0.92 -0.64 -2.57 -1.34
Weighted Average Shares Outstanding 12.82 Million 12.82 Million 55.04 Million 51.82 Million 27.03 Million 23.51 Million
Weighted Average Shares Outstanding (Diluted) 12.82 Million 12.82 Million 55.04 Million 51.82 Million 27.03 Million 23.51 Million
Gross Margin - - - - - 1.00
EBIT Margin - - - - - -0.94
Profit Margin - - - - - -1.26
EBITDA -52.28 Million -51.99 Million -49.58 Million -31.45 Million -69.1 Million -31.58 Million
Earnings Before Tax Margin - - - - - -0.94

Income Statement Charts